Literature DB >> 33326616

Subjects with blood group O are not at lower risk to acquire SARS-CoV-2 infection.

Nesrine Gamal1, Erica Villa2, Marco Rolli1, Monica Pecorari3, Giorgia Mirabella1, Elisabetta Bertellini4, Giovanni Ceccherelli1, Donatella Venturelli1.   

Abstract

Entities:  

Keywords:  ABO blood groups; COVID-19; Rh(D) antigen; SARS-CoV-2; coronavirus

Year:  2020        PMID： 33326616     DOI： 10.1111/vox.13062

Source DB:  PubMed          Journal:  Vox Sang        ISSN： 0042-9007            Impact factor:   2.144


× No keyword cloud information.
  3 in total

1.  Lack of neutralizing activity in nonconvalescent sera, regardless of ABO blood group and anti-A isoagglutinin titer.

Authors:  Daniele Focosi; Alfredo Rosellini; Pietro Giorgio Spezia; Lisa Macera; Maria Lanza; Aldo Paolicchi; Denise Biagini; Andreina Baj; Mauro Pistello; Fabrizio Maggi
Journal:  J Clin Virol Plus       Date:  2021-08-08

Review 2.  ABO blood groups and the risk of SARS-CoV-2 infection.

Authors:  Jörn Bullerdiek; Emil Reisinger; Birgit Rommel; Andreas Dotzauer
Journal:  Protoplasma       Date:  2022-04-01       Impact factor: 3.186

3.  Systematic review and meta-analysis of the effect of ABO blood group on the risk of SARS-CoV-2 infection.

Authors:  George Balaouras; Paolo Eusebi; Polychronis Kostoulas
Journal:  PLoS One       Date:  2022-07-28       Impact factor: 3.752
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.